Home Blog Page 2010

ArkBio Initiates Phase II Clinical Trial of AK0610, a Preventive Monoclonal Antibody for Respiratory Syncytial Virus Infection

SHANGHAI, Oct. 30, 2025 /PRNewswire/ — Shanghai Ark Biopharmaceutical Co., Ltd. (“ArkBio”) today announced the initiation of a Phase II clinical study of AK0610, a fully human monoclonal antibody designed to prevent respiratory syncytial virus (RSV) infection. Building on ArkBio’s previous experience and knowledge in development of RSV therapeutics, this milestone marks a major step forward in RSV prevention and enriches the company’s innovative anti-RSV drug portfolio.

The multicenter, randomized, double-blind, placebo-controlled, dose-escalation phase II study will assess the safety, tolerability, and pharmacokinetics of AK0610 Injection in healthy infants in China. The study will be conducted at five centers nationwide, jointly led by Professor Xin Ni of Beijing Children’s Hospital, Capital Medical University, and Professor Hanmin Liu of West China Second Hospital, Sichuan University.

RSV is a leading cause of acute lower respiratory tract infections (ALRTI) in children under 5 years of age worldwide. More than 80% of children become infected before their first birthday, and nearly all have been exposed at age two. Among those infected, approximately one-third may develop severe ALRTI, such as bronchiolitis or pneumonia. Infants under one year of age, particularly preterm infants, are at greatest risk of developing serious RSV-related complications, often requiring hospitalization. Given China’s large infant population and persistent RSV prevalence, the country faces a significant healthcare burden, underscoring the urgent need for novel, long-acting preventive interventions.

AK0610 is a monoclonal antibody targeting the pre-fusion F protein of RSV. It was isolated from a convalescent infant and subsequently engineered to enhance durability. Distinguished by its unique binding epitope and mechanism of action, AK0610 maintains robust neutralizing activity across RSV variants, especially RSV B strains. Preclinical data demonstrated strong antiviral activity with an excellent safety profile. In the completed phase I trial in healthy adults, AK0610 was safe, well-tolerated, and exhibited favorable pharmacokinetic properties. With an extended half-life, a single dose may provide season-long protection, positioning AK0610 as a promising new-generation long-acting antibody for prophylaxis of RSV infection in infants.

Professor Xin Ni stated:
“RSV remains the leading viral cause of hospitalization among infants and young children in China, especially those under one year of age, placing a heavy burden on families and the healthcare system. There is an urgent need for domestically developed innovative preventive antibodies capable of offering durable protection throughout the RSV season. The initiation of AK0610’s Phase II clinical study is an important milestone in advancing such preventive strategies. Evaluating its safety and pharmacokinetics in healthy infants is an essential step towards developing this antibody for China as well as the global vast infant population. We are optimistic that the study will pave the way for this promising drug candidate to safeguard the healthy growth of infants globally.”

Professor Hanmin Liu added:
“AK0610 is a fully human monoclonal antibody with a unique mechanism of action and excellent clinical potential. Its potent, highly specific neutralizing activity and extended half-life make it a strong candidate for RSV prevention. The rigorously designed phase II study will provide important data on its safety and pharmacokinetic characteristics in infants, establishing a solid foundation for future pivotal trials. Together with participating centers across the nation, we are committed to conducting this clinical trial with scientific rigor with a goal to reduce the burden of RSV-related diseases among infants.”

About ArkBio

ArkBio is a global biotech company focused on developing innovative therapeutics for respiratory, infectious, and pediatric diseases. Founded in 2014, it has built core technology platforms and a differentiated R&D pipeline through in-house R&D efforts and external collaboration. Key drug assets include ziresovir (AK0529), the first direct-acting RSV antiviral with positive pivotal phase III results, and AK0901, an ADHD therapeutic drug, both of which have filed NDA to China CDE for market approval.

ArkBio has established strategic partnerships with several multinational pharmaceutical companies and academic institutes, including Roche, Genentech, the Scripps Research Institute, the Institute of Microbiology of Chinese Academy of Sciences, domestic and international biotechnology companies, as well as venture capital institutions.

For more information, please visit: www.arkbiosciences.com 

Investor Inquiries: IR@arkbiosciences.com 

Jenscare released its multi-product portfolio’s, including LuX-Valve Plus TRINITY study, JensClip and Ken-Valve, remarkable clinical outcomes at TCT 2025 in the U.S.

BEIJING, Oct. 30, 2025 /PRNewswire/ — Jenscare Scientific Co., Ltd. (“Jenscare” or the “Company”) (HKEX: 9877), an innovative medical device company, recently released 6-month follow-up results of TRINITY Trial of LuX-Valve Plus, a promising self-developed TTVR system, and 1-year outcomes and challenging cases of JensClip and Ken-Valve, a proprietary TMVr system and TAVR (AR) system respectively, representing the Company’s diversified and high-potential multi-product portfolio, at TCT 2025 in the U.S..

6-Month Follow-up Results of LuX-Valve Plus TRINITY Study
-Released by Prof. Thomas Modine, CHU de Bordeaux-Haut-Leveque, France

TRINITY is a global prospective, multicenter, single-arm clinical trial, which primarily aims to evaluate the safety and efficacy of LuX-Valve Plus in application on patients with severe tricuspid regurgitation and high surgical risk. The study enrolled 161 patients from 20 centers around the world, among which, 18 centers were from France, Germany, Spain, Denmark, and the UK.

The average age of the patients (FAS + Roll-in group) is about 77 years old with an average STS score of 10.24%. 91.93% of the patients has atrial fibrillation, 32.92% has left heart surgery/intervention, 26.71% has pacemaker/ICD implanted. Patients are combined with multi other comorbidities, which formed a poor baseline and increased the risks of surgical treatment or difficulties of other interventional therapies. Over 75% of enrollments utilized valve sizes between 55mm and 70mm. The results show that the device success rate is about 97%, and the average device operation time is around 41.60 minutes with the shortest time being 11 minutes.

The safety indicators show that the overall CEC-adjudicated composite events rate at 6-month of FAS + Roll-in group is 19.9%. Cardiovascular mortality is 3.7%, the incidence of strokes is 0.6%, new onset renal failure is 1.2%, non-selective tricuspid valve surgery/intervention post procedure is 2.5%, major cardiac structural complications is 3.1%, severe bleeding (including fatal, life-threatening and extensive bleeding as defined by MVARC) is 5.0%, new pacemaker implantation due to AVB is only 8.7% (no change compared to that at 30 days). No events prevailed in myocardial infarction, major access site and vascular complications, and device-related pulmonary embolism.

The efficacy indicators show that the tricuspid regurgitation (TR) grade, NYHA classification, and QoL improved significantly at 6 months. 94.4% of the patients show no above moderate TR. 90.9% of them show postoperative NYHA class I/II. KCCQ score increased by around 19 pts on average. 6MWD increased by 39 meters on average.

Professor Thomas Modine concluded that LuX-Valve Plus TTVR system is an innovative device indicated for high-surgical risk patients with severe TR and demonstrates several advantages. First, it has radial-force independent anchoring mechanism, which is designed particularly for TV. Second, it indicates low demands on imaging quality, which is expected to significantly reduce device time. Third, it provides large size options, which enables wide applicability on large TV anatomies. The 6-month clinical outcomes of TRINITY Trial demonstrate good safety and performances, with improvements in quality of life and low rate of composite adverse events. The wide application on large anatomy patients provides encouraging treatment options for severe TR patients, while current therapies are limited. Further follow-ups of TRINITY trial and clinical evidence worldwide using LuX-Valve Plus system are underway. Currently, the U.S. FDA IDE-EFS for LuX-Valve Plus has completed full enrollment with excellent safety and efficacy outcomes.

Meanwhile, evidence supporting the efficacy and safety of the transjugular approach for LuX-Valve Plus was also presented. The advantages of the transjugular approach include low incidence of access site bleeding complications, reflecting high safety profile; shorter device operation time, demonstrating good procedural efficiency; and a low screening failure rate due to the anatomical structure of the jugular vein. Current data from the TRAVEL II and TRINITY studies show bleeding complication rates of 0% and 1.8% respectively, representing outstanding clinical outcomes.

One-Year Follow-Up Results of JensClip
-Released by Prof. Vinicius Esteves, University Hospitals in Cleveland, U.S.

The study of JensClip TMVr system is a prospective, multicenter, single-arm clinical trial, which primarily aims to evaluate the safety and efficacy of JensClip in application on patients with symptomatic degenerative mitral regurgitation (DMR) at high surgical risk. The study enrolled 114 patients from 18 centers in China.

The average age of the patients is about 71 years old with an average STS score of 7.65%. 63.2% of the patients has hypertension history, 41.2% has coronary artery disease, 30.7% has atrial fibrillation, and 91.2% has pre-operative NYHA class III/IV. The results show that the device success rate at 30 days is about 95%, and the average device operation time is around 67.53 minutes.

The safety indicators show that the all-cause mortality rate is 1.8%. The incidence of unplanned mitral valve intervention/surgery is 5.3%, and that of stroke is 1.8%. The incidence of renal failure, myocardium infarction, major bleeding, device releasing/locking failure, and clip related hemolysis are all 0.9%. No events prevailed in SLDA and device related air embolism.

The efficacy indicators show that the mitral regurgitation (MR) grade, NYHA classification, and QoL improved continuously at 1 year. 96.29% of the patients show no above moderate MR. 93.46% of them show postoperative NYHA class I/II. KCCQ score increased by around 20 pts on average. 6MWD increased by around 82m from the baseline.

Professor Vinicius Esteves concluded that JensClip is an innovative device intended for severe DMR, providing easy and reliable operation with unique designing features like continuous-adjustable locking system and independent grasping technique. The 1-year clinical outcomes demonstrated procedural safety and durable MR reduction.

One-Year Follow-Up Results of Ken-Valve
-Released by Prof. Anson Cheung, St. Paul’s Hospital, Canada

The study of Ken-Valve TAVR system is a prospective, multicenter, single-arm clinical trial, which primarily evaluates the safety and efficacy of Ken-Valve in application on patients with symptomatic aortic regurgitation (or combined with aortic stenosis) at high surgical risk. The study enrolled 142 patients from 15 centers in China.

The average age of the patients is about 70 years old with an average STS score of 5.87%. 61.97% of the patients has moderate to severe frailty, 71.83% has hypertension history, 42.96% has coronary artery disease, 48.59% has peripheral vascular disease, 51.41% has prior surgical history, and 99.30% has pre-operative NYHA class III/IV. The results show that the device success rate is about 97%, and the average device operation time is around 8.70 minutes.

The safety indicators show that all-cause mortality is 5.63%. The incidence of severe bleeding is 4.23%, and conversion to surgery is 1.41%. Both the incidence rate of stroke and valve migration is 2.11%. Both the incidence of acute renal dysfunction and needed for cardiopulmonary mechanical assistance is 0.7%. No events prevailed in coronary artery obstruction, thrombosis, and cardiac tamponade.

The efficacy indicators show that the aortic regurgitation (AR) reduction, NYHA classification, and QoL improved continuously at 1 year. 94.7% of the patients show no above moderate paravalvular leakage. 96.2% of them show postoperative NYHA class I/II. EQ-5D score increased by around 19 pts on average. The function and performance of Ken-Valve remain favorable with stable EOA and transvalvular gradient at 1 year.

Professor Anson Cheung concluded that Ken-Valve TAVR system is an innovative device indicated for high-surgical risk patients with severe AR or predominantly regurgitant mixed with aortic valve stenosis with several advantages. Ken-Valve has integrated clamping and radial force anchoring mechanism which can provide reliable anchoring force. It has a leak-proof ring which is expected to minimize PVL post-implantation. It provides large size options which enables wide applicability on large aortic valve anatomies. The deflectable delivery system allows better co-axiality and alignment when treating complex anatomies like horizontal heart. The 1-year clinical outcomes of the Ken-Valve Pivotal Trial demonstrated good safety and performances, with improvements in quality of life, stable EOA and transvalvular gradient, and low rate of composite adverse events. The wide application on large anatomy patients provides encouraging treatment options for severe AR patients while current therapies are limited.

About LuX-Valve Plus

LuX-Valve Plus, the proprietary TTVR system, is designed for patients with severe tricuspid TR and high surgical risk. LuX-Valve Plus breaks through multiple technical difficulties in tricuspid valve interventional therapy. With the design of innovative “interventricular septum anchoring” and “leakproof self-adaptive braided ring”, which enables non-radial anchoring of the valve implant and tend to effectively prevent AV block. LuX-Valve series product is designated by the FDA as a breakthrough device, is enrolled in the Total Product Life Cycle Advisory Program (TAP) pilot of the FDA and is selected for the Expert Panel Scientific Advice Pilot by the EMA. As of the latest update, close to 1000 implantation cases have been completed worldwide with the LuX-Valve series products, and the longest follow-up record has been over 6 years.

About JensClip

JensClip, the proprietary TMVr system, features an innovative self-locking design, which is expected to effectively improve mitral regurgitation and reduce leaflet tension. The valve clip allows for flexible shape adjustments, which is expected to enhance procedural safety and improve intraoperative maneuverability. Furthermore, its one-piece release mechanism is designed to minimize potential mis-operation risks associated with staged detachment, effectively reducing device operation time.

About Ken-Valve

Ken-Valve, the proprietary first-generation TAVR system, is designed for the treatment of patients with severe AR or combined with AS. Its innovative design accommodates a wide range of complex anatomies, significantly improving procedural safety and flexibility while reducing device operation time. It offers six annulus sizes – 23mm, 25mm, 27mm, 29mm, 31mm and 33mm. Its unique innovative design and applicability to complex anatomical challenges, such as large annulus and horizontal heart, can address the treatment needs of patients with large annulus for whom treatment options are relatively limited.

About Jenscare

Jenscare is an innovative medical device company, established in 2011. The Company has achieved a diversified and high-potential product portfolio of interventional treatment solutions for different types of structural heart diseases, including tricuspid valve disease, mitral valve disease, aortic valve disease and so on. The Company is continuing to expand its global business layout, enhancing product influence and clinical application scale, thereby laying a solid foundation for sustained high-speed growth. 

Ubiqconn Technology Takes the Spotlight at APSCC 2025, Driving Global Collaboration in SATCOM-Ready Mobility

Ubiquitous Connectivity Unites Global Satellite Leaders to Shape the Future of the Space Industry

TAIPEI, Oct. 30, 2025 /PRNewswire/ — Ubiqconn Technology, a leading provider of SATCOM-ready mobility and rugged computing solutions, will take center stage at the APSCC 2025 Conference (Asia-Pacific Space Community Council Conference 2025), held November 4–6 at the Taipei Marriott Hotel. Under the theme Ubiquitous Connectivity – Powering the Last Mile with SATCOM-Ready Mobility,” Ubiqconn will spotlight its innovative approach to integrating terrestrial communications, mobile computing, and satellite applications. Through this showcase, the company aims to bridge global space communication ecosystems and reaffirm its mission to enable seamless, borderless connectivity across industries and regions.

Ubiqconn Technology Takes the Spotlight at APSCC 2025, Driving Global Collaboration in SATCOM-Ready Mobility
Ubiqconn Technology Takes the Spotlight at APSCC 2025, Driving Global Collaboration in SATCOM-Ready Mobility

As a key co-organizing partner of APSCC 2025, Ubiqconn Technology brings deep industry expertise and facilitates cross-sector collaboration to strengthen Taiwan’s role as a strategic player in the Asia-Pacific space economy. The three-day conference gathers experts from over 25 countries, covering GEO, MEO, and LEO multi-orbit collaboration, AI-driven satellite operations, 5G NTN integration, and sustainable space development, marking Taiwan’s official entry into the global satellite network.

With the vision of “Ubiquitous Connectivity,” Ubiqconn Technology continues to build an integrated ecosystem that connects ground and orbital networks. Its product portfolio spans satellite gateways, SATCOM antennas, in-vehicle computers, rugged tablets, and unmanned ground control systems, enabling reliable communications across maritime, logistics, public safety, mining, and agricultural sectors.

“Ubiqconn Technology is committed to enabling ubiquitous connectivity that empowers industries to operate without boundaries,” said Paul Hsieh, CEO of Ubiqconn Technology. “By linking ground and space, we are shaping the future of resilient and intelligent communications for the Asia-Pacific region and beyond.”

Leveraging a robust foundation in electronics manufacturing and system integration, Ubiqconn Technology is fostering collaboration among industry, government, and academia to drive end-to-end vertical integration—from chip design and terrestrial communication modules to advanced space application platforms. Through its participation in APSCC 2025, Ubiqconn aims to strengthen global partnerships across the satellite value chain and reinforce its leadership in the Asia-Pacific space ecosystem.

About Ubiqconn Technology

Ubiqconn Technology is a leading provider of rugged mobile and satellite connectivity solutions, delivering value-added services across critical sectors including satellite communication, maritime, rugged smart mobility, and government. Guided by the vision of “Ubiquitous Connectivity,” Ubiqconn emphasizes user-centric thinking, agile go-to-market strategies, and engineering excellence to help clients solve real-world challenges and bring innovation to life.

For more information, please visit our website: www.ubiqconn.com.

IQAX and CargoNPay Partner to Launch AI-Driven eBL Shipping Instruction Solution

Collaboration sets a new benchmark for digital transformation in China’s freight industry.

HONG KONG, Oct. 30, 2025 /PRNewswire/ — IQAX, a global leader in digital trade intelligence technology, has entered a strategic partnership with CargoNPay, a premier logistics technology platform based in China. This collaboration integrates IQAX One intelligent trade ecosystem and its blockchain-based electronic Bill of Lading (eBL) solution with CargoNPay’s AI-powered document processing system, creating a seamless, secure end-to-end solution for freight forwarders across China.

At the core of the partnership is an industry-first AI-based B/L Shipping Instruction and blockchain-enabled electronic Bill of Lading (eBL) workflow. It is designed to automate, secure, and accelerate trade document processing.

Key features include:

1)    Automated Data Extraction: CargoNPay’s AI technology identifies, extracts, and verifies key data from customer documents to generate precise information required for eBL applications.

2)    Seamless Integration: Freight forwarders can transmit this data through CargoNPay’s platform to carriers connected to the IQAX network, enabling faster eBL initiation.

3)    Digital Issuance: IQAX eBL ensures the secure and efficient issuance of legally binding electronic bills of lading, digitizing the entire trade documentation process. 

This collaboration dramatically reduces manual data entry, minimizes human error, and shortens document turnaround times from days to just hours.

George Guo, CEO of IQAX, said, “We value CargoNPay’s industry-leading capabilities in AI-powered document recognition. The combination of technologies delivers unprecedented operational convenience for freight forwarders and advances the development of an international digital intelligence trade ecosystem. This aligns fully with our vision of empowering the logistics industry and creating enhanced value through strategic partnership.”

Edward  Ma, CEO of CargoNPay, added, “Partnering with IQAX has allowed us to realise the full potential of our AI technology in real-world logistics applications. By integrating IQAX’s trusted eBL services, we have achieved a fully closed-loop online service and established a digital hub that connects freight forwarders and carriers more effectively than ever.”

Beyond eBL functionality, CargoNPay users can now access the full range of IQAX One digital services, including real-time vessel scheduling, cargo tracking, inland transport monitoring, and electronic document submission, offering complete visibility and automation across the logistics value chain.

The AI-powered B/L creation and eBL issuance service is now available to CargoNPay users.

About IQAX 

IQAX is a digital trade intelligence company powering critical decisions across global supply chains. We help businesses act faster, build resilience and become more sustainable by solving their most complex challenges. From IQAX eBL to digital twins, our solutions embed our deep industry expertise within a proprietary frontier technology stack that incorporates IoT, blockchain, and AI. Our enterprise-grade solutions prioritise security, integration and interoperability, helping customers accelerate digital transformation. IQAX works with leading shipping lines, logistics providers, corporates, and financial institutions worldwide. For more information, visit www.iqax.com.

About CargoNPay

CargoNPay is a leading digital intelligent service platform in China, dedicated to digital transformation and innovative services within the international logistics industry ecosystem. Currently, the company’s many innovative products and services are at the forefront of the domestic industry, with nationwide coverage, providing users with a diverse range of comprehensive services. These include freight rate and schedule inquiries, cargo tracking, booking channels, domestic and international manifest declarations, customs declaration, insurance, AI document center services, an integrated electronic invoice system, multi-currency online payments, and supply chain finance. CargoNPay integrates internet technology, blockchain, and artificial intelligence application scenarios to connect freight forwarders, shipping companies, shipping agents, value-added service providers, banks, financial institutions, and other parties. The platform effectively addresses the pain points of traditional cross-border logistics companies — such as low efficiency, high costs, and funding bottlenecks — while also assisting industry enterprises in expanding, reducing costs, increasing efficiency, and achieving digital innovation and transformation.

SOGAGEM Expands Global Distribution Network to Drive K-Jewelry Exports

SEOUL, South Korea, Oct. 30, 2025 /PRNewswire/ — Korean fashion jewelry company SOGAGEM Co., Ltd. is accelerating its global distribution expansion, leveraging its AI and data-driven trade platform to open new export channels across Japan, the U.S., China, and Southeast Asia. The company’s strategy centers on building a next-generation global B2B ecosystem that integrates manufacturing, logistics, and digital marketing.

At the core of this initiative are SOGAGEM’s proprietary AI Jewelry Modular Designer (JMD) and Fulfillment Business Network (FBN). These systems automate product registration, recommend customized items for buyers, and connect to localized logistics services — enabling overseas partners to source Korean jewelry easily and deliver efficiently through regional fulfillment centers.

SOGAGEM has already established strategic partnerships in Japan, the U.S., and Vietnam, introducing innovative export models such as dropshipping and B2B marketplace integration. In collaboration with the Namdaemun Jewelry Association, the company also manages exclusive design IP content, offering verified product information that builds buyer trust and increases conversion rates.

CEO Moon Kyu-sik said, “SOGAGEM is more than a jewelry brand — it’s a technology-driven trade infrastructure company. By combining AI-based product matching and logistics optimization, we’re strengthening K-jewelry’s global export competitiveness.”

SOGAGEM plans to expand its fulfillment hubs across Southeast Asia and North America by 2026, while broadening its business scope beyond jewelry to beauty, fashion, and lifestyle sectors. Through these efforts, the company aims to evolve into a comprehensive AI-based digital trade ecosystem platform that connects Korean creators with the global market.

Indoor Air Pollution Cannot Be Ignored Clean Air Network Supports Businesses in Meeting the Challenge


HONG KONG SAR – Media OutReach Newswire – 30 October 2025 – The World Health Organization reports that over 3 million people worldwide die each year from indoor air pollution. In Hong Kong, people spend nearly 90% of their time indoors.[1] For office workers who often have long working hours, the air quality in workplaces directly affects their health, work efficiency, and, ultimately, corporate productivity. Environmental group Clean Air Network is currently driving various programs to raise public awareness about the threats of indoor air pollution. The organization also collaborates with businesses to create safe and healthy working environments.

Many people believe that staying indoors protects them from outdoor vehicle emissions and poor air quality. However, a variety of harmful indoor air pollutants may also be present, such as suspended particulates, volatile organic compounds (VOCs), biological contaminants like mold and dust mites, among others. Prolonged exposure may lead to cancer, respiratory and cardiovascular diseases, asthma, skin allergies, and more. The causes of indoor air pollution are complex and can be influenced by factors such as building use, chemical substances in the environment, ventilation, temperature, and humidity.

Patrick Fung, Chief Executive Officer of Clean Air Network, said, “There are already feasible solutions in the market to help businesses manage indoor air quality. Although the Hong Kong Stock Exchange does not currently require companies to disclose indoor air quality information in ESG reports, we firmly believe that the health and wellbeing of employees, consumers, and tenants are central to the core values of most companies. Therefore, we encourage more businesses to actively manage indoor air quality as a demonstration of their commitment.”

Common indoor air pollution threats faced by office workers include VOCs released from printing equipment[2] and formaldehyde emitted from office renovation materials and furniture[3]. In addition, studies have found that due to poor ventilation in some Hong Kong buildings, carbon dioxide exhaled by employees can accumulate and become a source of pollution.[4] Extended exposure to high levels of carbon dioxide can cause fatigue, difficulty concentrating, and even headaches.

Currently, there are no laws in Hong Kong regulating indoor air quality. The government promotes indoor air management through the voluntary Indoor Air Quality Certification Scheme. Patrick Fung believes that the general public places great importance on physical and mental health, and encourages businesses to actively respond to employees’ concerns by creating safe breathing environments. To this end, Clean Air Network has launched a Partnership Program to help businesses and NGOs monitor indoor air quality and explore improvement measures.

Meanwhile, to enhance public awareness of indoor air quality, Clean Air Network will invite citizens over the next two months to measure air pollutants in frequently visited places such as gyms, shopping malls, and restaurants using portable instruments. The data collected will be used to create an online interactive map for public reference.

For more information, please visit Clean Air Network’s website: https://hongkongcan.org/indoor-air-quality-iaq/ .


[1] Chau C K, Tu E Y, Chan D W T and Burnett J. Estimating the total exposure to air pollutants for different population age groups in Hong Kong. Environment International, Vol. 27, p.617-630, 2002.
[2] Hui, P.-S., K.-W. Mui, and L.-T. Wong, Influence of indoor air quality (IAQ) objectives on air-conditioned offices in Hong Kong. Environmental Monitoring and Assessment, 2008. 144: p.315-322.
[3] Lee, S.-C., et al., Inter-comparison of air pollutant concentrations in different indoor environments in Hong Kong. Atmospheric Environment, 2002. 36(12): p. 1929-1940.
[4] Zhou, Y., et al., Airborne Bacteria in Outdoor Air and Air of Mechanically Ventilated Buildings at City Scale in Hong Kong across Seasons. Environmental Science & Technology, 2020. 54(19):p.11732-11743.

Hashtag: #IAQ #publichealth #indoorairpollution #ESG #environment #wellbeing




The issuer is solely responsible for the content of this announcement.

About Clean Air Network (https://hongkongcan.org)

(‘CAN’) is the only non-governmental organisation in Hong Kong focused on air issues. We seek to achieve our vision ‘Clean Air for All’ in Hong Kong through constructive dialogue and integrating various resources.

Raythink Technology Showcases Next-Generation All-Round Security Systems at 2025 CPSE Expo

YANTAI, China, Oct. 30, 2025 /PRNewswire/ — The 20th China Public Security Expo (CPSE), recognised as the world’s premier security exhibition, commenced in Shenzhen on October 28, drawing over 1,000 exhibitors. Raythink Technology Co., Ltd. (“Raythink”), a pioneer in thermal imaging, drew significant attention at Booth 1A31, showcasing its advanced infrared products and system solutions centred on its innovative All-Round Security Systems.

Raythink showcasing its latest innovations at CPSE 2025 (Booth1-A31)
Raythink showcasing its latest innovations at CPSE 2025 (Booth1-A31)

A Product Matrix for All-Round Security

At the core of the showcase was Raythink’s integrated product matrix, engineered to create a seamless security ecosystem spanning land, sea, and air domains.

  • 360°Infrared Panoramic Camera

The SilentW-U series provides 360° panoramic monitoring and can be seamlessly integrated with multi-spectrum PTZ cameras, enabling detailed and automatic target tracking.

These cameras integrate infrared, visible light, and LRF for comprehensive coverage. Designed for reliability, they deliver precise imaging in extreme weather and low visibility, ensuring 24/7 security.

  • 360° Dual-Spectrum Search & Track System

The SI4 system combines panoramic search and PTZ tracking in one unit. Its infrared layer provides all-weather detection, while the dual-spectrum PTZ camera enables immediate visual confirmation, completing the workflow from alert to identification.

From Multi-Dimensional Perception to Cognitive Intelligence

Moving beyond standalone hardware, Raythink’s competitive edge lies in the deep fusion of multi-spectral sensing technologies and AI empowerment. By leveraging its latest AI classification algorithms, Raythink’s security systems can intelligently detect and track various targets, including people, vehicles, and vessels, with exceptional precision while significantly reducing false alarms. These systems also support advanced innovative functions such as fire point detection, tripwire intrusion alerts, and area intrusion monitoring. This deep integration enables solutions that not only perceive but truly understand complex environments.

From Reactive Monitoring to Proactive Threat Detection

Powered by a robust product matrix and intelligent technology, Raythink delivers comprehensive solutions for critical applications, including forest fire prevention and perimeter security. The system establishes a complete “Perception-Tracking-Analysis” management mechanism. Devices act as perception nodes, collecting real-time data. Upon detecting anomalies, the system locks onto targets and evaluates threats using AI, generating early warnings. This system shifts security from passive monitoring to proactive threat detection, improving efficiency and precision.

As a leader in thermal imaging innovation, Raythink remains dedicated to advancing security technologies, empowering industries with intelligent, reliable, and future-ready solutions.

For more information:
Email: sales@raythink-tech.com
Website: https://www.raythink-tech.com/

Latham & Watkins Names New Partners and Counsel

The annual promotion of associates highlights the firm’s depth of talent and strengths in key practice areas and markets around the world.

NEW YORK, Oct. 30, 2025 /PRNewswire/ — Latham & Watkins LLP1 is pleased to announce that 40 associates have been elected to the partnership and another 56 associates have been promoted to the role of counsel, effective January 1, 2026. The associate promotions announced today follow the election of 19 counsel to the partnership earlier this year.

“Today is an important and exciting day for our firm as we recognize and celebrate an amazing group of lawyers, welcoming them as partners and counsel. I am extremely proud of them,” said Rich Trobman, Chair and Managing Partner of Latham & Watkins. “They have contributed significantly to the growth, success, and culture of Latham, and their promotions highlight the incredible depth of talent we have at our firm. Each lawyer embodies our hallmark values of teamwork, dedication, and exceptional client service — and each is committed to our shared pursuit of excellence in delivering outstanding results for our clients.”

“This milestone recognizes the talent and skills of the attorneys being promoted. And this robust class reflects the value we place on building client teams and cultivating the best legal talent in the industry,” added partner Michelle Carpenter, Chair of the firm’s Associates Committee. A signature Latham tradition, the Associates Committee consists of both partners and associates who collaborate on key responsibilities, including recommending promotions to partner and counsel each year.

The 40 associates elected to the partnership are:

EUROPE

Brett Carr (London) is a member of the Emerging Companies & Growth Practice. He advises payment service providers, payment system operators, stablecoin and electronic money issuers, technology companies, fintech investors, and lenders on regulatory issues at the intersection of payments, lending, and digital assets.

Michael Colle (Paris) is a member of the M&A and Private Equity Practice. He advises private equity firms, their portfolio companies, and corporates on a range of M&A and private equity transactions, hybrid capital, and initial public offerings (IPOs) across industries.

Chris Cox (London) is a member of the M&A and Private Equity Practice. He represents sponsors, fund vehicles, and corporates on acquisitions, exits, and majority and minority investments across asset classes, with a focus on real estate and infrastructure.

Calum Docherty (London) is a member of the Data & Technology Transactions Practice. He advises clients on technology and data issues, with a focus on data protection and information law, artificial intelligence, digital regulation, product counselling, incident response, and multijurisdictional regulatory compliance and investigations.

Tamryn Gallagher (London) is a member of the Banking & Private Credit Practice. She advises private equity sponsors, their portfolio companies, and corporate borrowers on a wide range of financings, including domestic and cross-border acquisition and leveraged financings, bridge financings, refinancings, restructurings, and other secured lending transactions.

Jonathan Ritson-Candler (London) is a member of the Capital Markets Practice. He advises financial institutions and market infrastructure providers on UK and cross-border financial regulatory issues, including legal and regulatory risk management, asset management and financial institution M&A, and compliance with UK and European regulatory matters.

Harriet Stephenson (London) is a member of the M&A and Private Equity Practice. She advises corporates and investors on cross-border transactions and events across the corporate life cycle, including UK and international M&A transactions, public takeovers, board advice in takeover situations, joint ventures, corporate reorganizations, and corporate law and governance matters.

Andrea Stincardini (Milan) is a member of the M&A and Private Equity Practice. He represents private equity funds, their portfolio companies, and Italian corporations in M&A, joint venture, private equity, divestiture, strategic commercial contracts, corporate governance, and venture capital transactions.

Julie Van der Meersche (London) is a member of the Banking & Private Credit Practice. She represents private equity sponsors, their portfolio companies, and corporate borrowers in cross-border debt finance transactions, including leveraged buyouts, refinancings, restructurings, and other secured lending transactions at every level of the capital structure.

Dominik Waldvogel (Frankfurt) is a member of the M&A and Private Equity Practice. He advises private equity and other financial investors as well as corporates on German and cross-border M&A transactions across industries.

UNITED STATES

Shane Alexander (Los Angeles) is a member of the Banking & Private Credit Practice. He represents private equity sponsors and corporate borrowers in complex domestic and cross-border financing transactions, including syndicated and private credit financings, acquisition and carve-out financings, asset-based and cash flow facilities, liability management transactions, debt restructurings, and workouts.

Savannah Burgoyne (Washington, D.C.) is a member of the White Collar Defense & Investigations Practice. She advises institutional and individual clients on government and internal investigations and regulatory and compliance matters, including enforcement, compliance, and litigation involving the FCPA, Bank Secrecy Act, securities laws, anti-kickback statutes, and federal civil rights laws, as well as in response to congressional inquiries.

Shannon Cheng (Orange County) is a member of the M&A and Private Equity Practice. She advises public and private companies in the technology, healthcare and life sciences, and aerospace industries on M&A transactions and corporate governance matters.

Shanta Chirravuri (New York) is a member of the M&A and Private Equity Practice. She advises private equity funds, their portfolio companies, and other strategic investors on M&A, dispositions, leveraged buyouts, joint ventures, carve-outs, and general corporate matters.

Michael Cromer (New York) is a member of the Real Estate Practice. He represents banks and institutional investors in commercial real estate financings and transactions across asset classes, including with respect to construction loans, mezzanine financings, workouts, and restructurings.

Abigail Friedman (Washington, D.C.) is a member of the Transactional Tax Practice. She advises public and private companies, partnerships, investors, and financial institutions on transactional tax matters, particularly those involving strategic cross-border and private equity M&A, capital markets offerings, and financing transactions.

Daniel Gherardi (Bay Area) is a member of the Securities and M&A Litigation Practice. He represents and advises public and private companies, executives, and boards of directors in securities class actions, shareholder derivative litigation, contract disputes, government investigations, and other complex litigation matters.

Ryan Gold (New York) is a member of the Capital Markets Practice. He represents corporate, private equity, and banking clients on capital markets, securities, and corporate governance matters, with a focus on equity-linked securities offerings, complex corporate financings, and debt and capital restructuring transactions.

Brad Guest (Washington, D.C.) is a member of the M&A and Private Equity Practice. He represents private equity firms and their portfolio companies, as well as private and public companies, in mergers, acquisitions and other complex domestic and cross-border business transactions, including leveraged buyouts, carve-outs, add-on transactions, divestitures, restructurings, and controlling and minority investments, as well as general corporate and governance matters.

Robin Gushman (Bay Area) is a member of the Antitrust & Competition Practice. She represents public and private companies in antitrust litigation, government investigations, and complex commercial disputes, including consumer class actions and matters involving monopolization, conspiracy, unfair competition, and merger-related claims.

Alisa Hand (New York) is a member of the Executive Compensation, Employment & Benefits Practice. She advises companies, sponsors, and executives on employee benefits and executive compensation matters, including employment agreements, severance agreements, and equity-based and other incentive compensation arrangements, as well as compensation and benefits issues in corporate transactions.

Mike Hart-Slattery (Washington, D.C.) is a member of the Investment Funds Practice. He advises private equity sponsors, sovereign wealth funds, and investment advisers on SEC regulation, M&A involving asset managers, fund formation, management team spinouts, minority stake investments, and cross-border regulatory matters.

Clayton Heery (Houston) is a member of the M&A and Private Equity Practice. He advises public and private companies, boards of directors, and senior management across a range of M&A, capital markets, corporate governance, and other strategic transactions in a variety of industries, with a particular focus on energy, infrastructure, and technology.

Deborah Hinck (Boston) is a member of the Data & Technology Transactions Practice. She advises clients on intellectual property, privacy, and data security matters, including the IP, technology, and data privacy aspects of commercial contracts, licensing agreements, M&A, commercial transactions, and capital markets financings, with a focus on AI, digital health, and technology transactions.

Christian Hollweg (San Diego) is a member of the Emerging Companies & Growth Practice. He advises emerging growth companies and venture capital investors on transactional and operational matters throughout the company life cycle, including formation and structuring, equity and debt financings, corporate governance, and exit strategies.

David Johnson (Washington, D.C.) is a member of the Antitrust & Competition Practice. He represents clients in antitrust trials, private antitrust litigation, and government antitrust investigations, including trials and litigation regarding business mergers, claims of anticompetitive conduct, and monopolization.

Sandy Kugbei (New York) is a member of the Capital Markets Practice. He advises issuers and investment banking firms on domestic and cross-border capital markets transactions, including IPOs, direct listings, follow-on equity offerings, and investment grade and high-yield debt offerings, and on general corporate and US securities law matters.

Lauren Lefcoe (Bay Area) is a member of the M&A and Private Equity Practice. She represents publicly traded and privately held companies at all stages on M&A, dispositions, carve-outs, controlling and minority investments, and other strategic corporate transactions across a range of industries, with a particular focus on the technology and life sciences sectors.

Anne Malinee (Washington, D.C.) is a member of the Complex Commercial Litigation Practice. She represents individuals, private equity firms, and public companies as both plaintiffs and defendants in business disputes involving breach of contract, copyright infringement, unfair competition, trademark infringement, fraud, trade secret misappropriation, restrictive covenant violations, and equitable claims.

Kaj Nielsen (New York) is a member of the Capital Markets Practice. He represents issuers and underwriters in equity and debt capital markets transactions, including IPOs, public and private offerings of equity and debt securities, and other corporate finance transactions.

Samuel Niles (Boston) is a member of the Capital Markets Practice. He advises boards of directors, management teams, and financial institutions on corporate, securities, and finance matters, including IPOs, equity and equity-linked public offerings, PIPEs, and at-the-market offerings, as well as emerging company venture financing, corporate governance, and strategic matters, with a focus on the life sciences and technology industries.

Alice Parker (Houston) is a member of the M&A and Private Equity Practice. She represents energy companies, private equity funds and their portfolio companies, and private capital clients in private M&A transactions, joint ventures, and commercial agreements, with a particular focus on the energy and infrastructure sectors.

Harris (Hai) Pham (Los Angeles) is a member of the Banking & Private Credit Practice. He represents banks, direct lenders, and corporate borrowers on a range of complex financing transactions, including acquisition financings, recurring-revenue based financings, cross-border transactions, and restructurings.

Nathan Sandals (Boston) is a member of the Complex Commercial Litigation Practice. He represents companies in commercial litigation arising from corporate transactions, consumer class actions, founder disputes, False Claims Act and Anti-Kickback Statute claims, and insurance coverage disputes, with a focus on the life sciences and technology sectors.

Will Schildknecht (Los Angeles) is a member of the Connectivity, Privacy & Information Practice. He advises companies on managing risk in the development of innovative technology, maintaining effective compliance programs, and navigating government and internal investigations, with a focus on AI, privacy, cybersecurity, and consumer protection.

Samuel Steinman (New York) is a member of the Real Estate Practice. He advises public and private clients, including private equity funds, sovereign wealth funds, pension funds, REITs, and public companies, on complex commercial real estate transactions such as joint ventures, preferred equity transactions, financings, acquisitions, dispositions, restructurings, and M&A transactions.

Jennifer Tian (Chicago) is a member of the Investment Funds Practice. She advises private equity sponsors on regulatory matters, including compliance with the Investment Advisers Act and Investment Company Act, investment structuring, SEC examinations and enforcement, M&A transactions involving registered investment advisers, and ongoing reporting requirements.

Laki Triantafylidis (Boston) is a member of the M&A and Private Equity Practice. He represents private equity sponsors, their portfolio companies, and strategic buyers and sellers in private equity investments, acquisitions, dispositions, growth equity and venture capital financings, healthcare and life sciences transactions, corporate governance, and portfolio company management.

Aida Vajzovic (New York) is a member of the Real Estate Practice. She represents public and private clients in commercial real estate transactions, including acquisitions, dispositions, joint ventures, and financings involving a variety of asset classes, in particular multifamily, office, hotel, retail, industrial, and mixed-use properties.

Michael Zucker (Chicago) is a member of the Transactional Tax Practice. He advises private equity firms and public and private companies on the tax aspects of commercial transactions, including M&A, joint ventures, debt and equity financings, tax-free reorganizations, and energy transition matters such as renewable energy tax credits.

The 56 associates promoted to counsel are: 

ASIA

Esha Goel (Singapore) is a member of the Capital Markets Practice. She advises issuers and underwriters on capital markets transactions, with a focus on India, as well as on US and international securities offerings and public and private debt and equity offerings across industries and jurisdictions.

Kelly Teoh (Singapore) is a member of the Capital Markets Practice. She advises clients on capital markets transactions, mergers and acquisitions, and strategic investments, as well as on corporate governance and compliance matters for listed companies.

Rob Thompson (Singapore) is a member of the Project Development & Finance Practice. He represents lenders, export credit agencies, development finance institutions, sponsors, and borrowers on large-scale, cross-border project development, financing, and M&A in the energy and infrastructure industry, including oil and gas, mining, power, energy transition, digital infrastructure, and transport projects.

Yanyan Yang (Hong Kong) is a member of the Antitrust & Competition Practice. She advises clients on global merger control and antitrust investigations, particularly in matters before China’s antitrust authority and other Asian antitrust agencies, and across sectors including semiconductors, agriculture, pharmaceuticals, oil and gas, industrial, entertainment, and telecommunications. 

Yao Yang (Hong Kong) is a member of the M&A and Private Equity Practice. She represents private equity firms and corporate clients in private equity investments and M&A transactions in Asia and globally, including control acquisitions, carve-outs, joint ventures, and growth capital and minority investments.

Elena Yeung (Singapore) is a member of the M&A and Private Equity Practice. She advises private equity sponsors and their portfolio companies, as well as corporate clients, on complex cross-border M&A and joint ventures in the Asia Pacific region.

EUROPE

Steffen Augschill (Düsseldorf) is a member of the M&A and Private Equity Practice. He advises clients on M&A, with a focus on going-private transactions and reorganizations, and on stock corporation law matters across a range of industries.

Carlos Betoret (Madrid) is a member of the Antitrust & Competition Practice. He advises international companies on global, EU, and Spanish competition law, representing clients before the European Commission and the Spanish Competition Authority in matters involving merger control, cartel, and abuse of dominance investigations, as well as horizontal and vertical agreements.

Charlie Bowden (London) is a member of the Executive Compensation, Employment & Benefits Practice. He advises clients on all aspects of contentious and non-contentious UK employment law, including in relation to employee restructuring exercises, restrictive covenant disputes, cross-border investigations, board-level exits, and the intersection between employment law and financial services regulatory compliance.

Niklas Brüggemann (Munich) is a member of the Antitrust & Competition Practice. He advises companies on the full spectrum of competition law, including EU and German antitrust law, tech regulation, merger control, foreign direct investment control, and civil antitrust litigation.

Jennifer Cadet (London) is a member of the M&A and Private Equity Practice. She represents clients in cross-border corporate transactions, including M&A and de-SPAC transactions, reorganizations, joint ventures, and general corporate matters across a range of industries, including technology, retail, entertainment, and healthcare.

Elva Cullen (London) is a member of the Data & Technology Transactions Practice. She advises clients on intellectual property, information technology, and commercial contracts, including in the context of M&A and private equity transactions, with a focus on large-scale, multi-jurisdictional matters.

Kamal Dalal (London) is a member of the Structured Finance Practice. She advises clients on a range of structured finance transactions with a focus on credit solutions, including traditional and synthetic securitization, repacks, and receivables financings, particularly with regard to digital infrastructure and emerging assets, including data centers and GPUs.

Rebecca Fielding (London) is a member of the Executive Compensation, Employment & Benefits Practice. She advises multinational corporations on employment matters, including workforce management, compliance, workplace discrimination, executive compensation, and cross-border employment challenges.

Louise Gurly (Paris) is a member of the M&A and Private Equity Practice. She advises clients on a range of M&A and private equity transactions, as well as corporate law. 

Katharina Intfeld (Düsseldorf) is a member of the M&A and Private Equity Practice. She advises clients on domestic and cross-border M&A transactions, as well as on corporate law.

Thomas Lane (London) is a member of the International Arbitration Practice. He advises clients on international arbitration, complex commercial litigation, export controls, economic sanctions, and customs matters, representing both states and private companies in high-value disputes and regulatory matters.d

Lina Le Roux (London) is a member of the Transactional Tax Practice. She advises clients on UK and international tax aspects of corporate and finance transactions, with emphasis on structured finance, restructurings, multijurisdictional tax planning, and tax-related financing and structuring.

Giuseppe Liotine (Brussels) is a member of the Antitrust & Competition Practice. He advises on the full range of EU and global competition issues, including merger control, cartels, and abuse of dominance, in the technology, life sciences, energy (including renewables), and consumer goods sectors, with experience coordinating deals across Europe, the Middle East, and US.

Aurélien Lorenzi (Paris) is a member of the Banking & Private Credit Practice. He advises clients on complex financings, with a particular emphasis on leveraged finance and debt capital market transactions and restructurings.

Felicitas Mayer-Theobald (Munich) is a member of the Transactional Tax Practice. She advises clients on international and transactional tax law, particularly involving investment fund matters, M&A and private equity transactions, and private equity fund structures and taxation.

Vanessa McLellan (London) is a member of the Project Development & Finance Practice. She advises project developers and financial investors on all aspects of the development of complex energy and infrastructure projects across all major industry sectors.

Oliver Mobasser (London) is a member of the Healthcare & Life Sciences Practice. He advises clients on a range of technology, IP, and data-focused transactions and matters in the healthcare and life sciences industry, including emerging and established multinational pharmaceutical, biotechnology, digital health, and medical technology companies and their investors. 

Samantha Peacock (London) is a member of the M&A and Private Equity Practice. She advises clients on corporate matters, including M&A, venture capital investments, and private equity transactions, with a focus on the healthcare and life sciences sectors.

Virginie Terzic (Paris) is a member of the Banking & Private Credit Practice. She advises clients on financing matters, with particular emphasis on leveraged finance and debt capital market transactions.

Simon Troch (Brussels) is a member of the Antitrust & Competition Practice. He advises clients on Belgian and EU competition law, including abuse of dominance, cartel matters, foreign subsidies, merger control, and general EU law, with a focus on complex litigious matters before the EU courts in Luxembourg.

UNITED STATES

Thomas Alcorn (Austin/Los Angeles) is a member of the Banking & Private Credit Practice. He represents institutional arrangers, lenders, and equity sponsors in cross-border financing transactions, restructurings, and acquisition and recapitalization, asset-based, NAV, recurring revenue-based, subscription line, and working capital financings.

Lucas Balchun (Washington, D.C.) is a member of the Capital Markets Practice. He advises clients including private equity firms, investment banks, and companies on a broad range of complex corporate finance, securities regulation, and general securities and corporate matters.

Molly Barron (Washington, D.C.) is a member of the Antitrust & Competition Practice. She represents corporate clients in complex civil antitrust litigation in state and federal courts, including multidistrict litigation, class actions, and business-to-business litigation involving claims of monopolization, monopsonization, price-fixing, conspiracy, refusal to deal, fraud, and state unfair competition laws.

Ali Beidoun (Chicago) is a member of the Investment Funds Practice. He advises private fund sponsors, investors, and joint venture participants on all aspects of forming, investing in, and operating private investment funds across multiple investment areas and asset classes, including buyout funds, credit and debt, growth equity, fund of funds, real estate, energy and power, and infrastructure

Daniel Bop (Chicago) is a member of the Executive Compensation, Employment & Benefits Practice. He advises privately held and publicly traded companies, private equity sponsors, and executives on compensation and benefits matters, including issues arising in M&A, IPOs, employment and separation agreements, equity-based compensation, and deferred compensation arrangements.

Natasha Burnett (New York) is a member of the M&A and Private Equity Practice. She advises private equity funds and companies on mergers, acquisitions, dispositions, joint ventures, co-investments, carve-outs, and corporate matters. 

Maeve Chandler (New York) is a member of the Structured Finance Practice. She represents banks, issuers, underwriters, investors, placement agents, borrowers, lenders, funds, and other financial institutions in structured finance, securitization, and secured financing transactions, including asset-backed securities, warehouse facilities, and revolving credit facilities.

Chen Chen (Bay Area) is a member of the Healthcare & Life Sciences Practice. She represents public and private life sciences companies in strategic and commercial transactions involving complex intellectual property issues, with a focus on licensing, partnering, and collaboration transactions.

Jiyeon Chun (New York) is a member of the Project Development & Finance Practice. She represents sponsors, developers, equity investors, commercial banks, and other financial institutions in the development and financing of energy and infrastructure projects, including solar, wind, and other renewable energy projects.

Ryan Clore (Washington, D.C.) is a member of the Data & Technology Transactions Practice. He advises clients on technology transactions involving intellectual property development and licensing, information technology, strategic relationships, complex services agreements, and mergers and acquisitions, with a particular focus on the video game industry.

Christopher D’Agostino (Washington, D.C.) is a member of the White Collar Defense & Investigations Practice. He advises clients on white collar defense, corporate compliance, and internal and government-facing investigations, including in the areas of anti-corruption, anti-money laundering, consumer protection, healthcare fraud, and drug enforcement.

Nicole Goldman (New York) is a member of the Project Development & Finance Practice. She represents financial institutions, private equity firms, strategic sponsors, and developers in project financings, acquisition financings, and other energy and infrastructure-related secured lending transactions.

Melanie Grindle (San Diego) is a member of the Intellectual Property Litigation Practice. She represents clients in IP disputes, with a particular focus on trademark, trade dress, and trade secret litigation, across industry sectors.

Zuzanna (Zuza) Gruca (Bay Area) is a member of the Capital Markets Practice. She advises public and private companies and investment banks on capital-raising transactions, including IPOs, follow-on equity offerings, notes offerings, and financings, and on securities, disclosure, and corporate governance matters.

Kathryn Harrington (Los Angeles) is a member of the Transactional Tax Practice. She advises clients on the US federal income tax consequences of structured financings, securities offerings, mergers and acquisitions, and bank and private credit financings.

Alexis Kellert Godfrey (New York) is a member of the White Collar Defense & Investigations Practice. She represents clients in a range of high-stakes white collar matters, complex commercial and securities litigation, and sensitive internal investigations across industries.

Evan Kirsch (New York) is a member of the Emerging Companies & Growth Practice. He advises private and public companies, venture capital investors, and private equity firms involved in the technology, life sciences and other growth industries on a broad range of complex transactional and operational matters, including venture, growth capital, and private equity financings, M&A, joint ventures, company formation, and corporate governance matters.

Denny Lee (Houston) is a member of the M&A and Private Equity Practice. He advises public and private companies, private equity sponsors, financial advisors, and special committees on mergers and acquisitions, take-privates, spinoff and carve-out transactions, joint ventures, corporate finance transactions, and corporate matters.

Cory Lewis (Boston) is a member of the M&A and Private Equity Practice. He advises private equity sponsors and their portfolio companies on transactions and corporate matters, including leveraged buyouts, carve-outs, spinoffs, joint ventures, recapitalizations, restructurings, and ongoing general corporate matters.

Corey McGehee (San Diego) is a member of the Complex Commercial Litigation Practice. He represents clients in insurance coverage disputes, bad-faith litigation, and environmental and regulatory disputes, including first- and third-party insurance disputes, business interruption, commercial general liability, director and officer liability, product liability, toxic tort, and complex commercial matters.

Julia Miller (New York) is a member of the White Collar Defense & Investigations Practice. She represents clients in white collar defense and investigations, as well as in complex commercial and securities litigation, including government investigations, enforcement actions, internal corporate investigations, securities class actions, and commercial litigation, with particular experience advising cryptocurrency and AI companies.

Jessica Saba (Washington, D.C.) is a member of the Complex Commercial Litigation Practice. She represents clients in state and federal courts at the trial and appellate level, with a focus on trade secrets litigation and related forensic investigations, as well as in other complex commercial and corporate disputes, including false advertising, copyright, business torts, and breach of contract cases.

Joseph Sung (Chicago) is a member of the Banking & Private Credit Practice. He represents financial institutions, private equity firms, and corporate borrowers in leveraged finance transactions, including acquisition financings, recapitalizations, working capital financings, and domestic, cross-border, and multicurrency financings.

Greg Swartz (Los Angeles) is a member of the Complex Commercial Litigation Practice. He represents clients in commercial disputes and regulatory enforcement proceedings, including contract disputes, unfair competition claims, corporate governance and partnership disputes, government investigations, and antitrust litigation across a range of industries.

Adam Tamzoke (New York) is a member of the Shareholder Activism & Takeover Defense and M&A and Private Equity Practices. He advises US and foreign public companies and their boards on shareholder activism, hostile takeover bids, crisis management, and corporate governance matters.

Margaret Upshaw (Washington, D.C.) is a member of the Supreme Court & Appellate Practice. She represents clients in appellate litigation and complex matters before all levels of the judiciary, including the US Supreme Court, involving class actions, data privacy, contracts, and constitutional law.

Katherine Webb (New York/Los Angeles) is a member of the Banking & Private Credit Practice. She represents direct lenders, banks, and other financial institutions, as well as corporate borrowers and other private and public entities in financing transactions, including cross-border and domestic facilities, investment grade facilities, direct lending transactions, acquisition financings, syndicated loans, secured transactions, asset-based loans, and margin loan financings.

Roland Young (Los Angeles) is a member of the Structured Finance Practice. He represents asset managers, business development companies, and financial institutions in financing transactions, including fund financings, asset-backed lending facilities, collateralized loan obligations, direct lending and origination platforms, asset securitizations, and joint venture financings. 

Laura Zabele (Boston/Los Angeles) is a member of the Complex Commercial Litigation Practice. She advises and represents clients in litigation involving employment law matters, pay equity, whistleblower retaliation, discrimination and harassment, breach of contract and wrongful termination, employee mobility and IP, leave and accommodation, wage/hour issues, and the California Private Attorneys General Act.

Yanyan Zhou (Los Angeles) is a member of the Healthcare & Life Sciences Practice. She advises private equity firms, physician practices, life sciences and digital health companies, hospitals, and strategic investors on transactions and regulatory matters in the healthcare industry, including mergers and acquisitions, strategic affiliations, joint ventures, regulatory approvals, licensing, and compliance.

Contact: pr@lw.com

About Latham & Watkins 

Latham & Watkins is a leading global law firm that brings together exceptional legal talent in financial centers around the world to advise on complex transactions, litigation, and regulatory matters. The firm’s deep market and product knowledge, industry experience, vast scale, and commitment to innovation and excellence help clients navigate their most critical challenges and achieve their goals.

Notes to Editors

  1. Latham & Watkins operates worldwide as a limited liability partnership organized under the laws of the State of Delaware (USA) with affiliated limited liability partnerships conducting the practice in France, Hong Kong, Italy, Singapore, and the United Kingdom and as an affiliated partnership conducting the practice in Japan. Latham & Watkins operates in Israel through a limited liability company, in South Korea as a Foreign Legal Consultant Office, and in Saudi Arabia through a limited liability company.